MedPath

Clinical Comparison of Two Daily Disposable Contact Lenses

Not Applicable
Completed
Conditions
Refractive Errors
Interventions
Device: Verofilcon A contact lenses
Device: Somofilcon A contact lenses
Registration Number
NCT04865354
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this study is to compare the clinical performance of PRECISION1™ contact lenses to Clariti® 1 day contact lenses.

Detailed Description

Subjects will be expected to attend 3 study visits and wear the study lenses daily for at least 10 hours per day. On the day prior to Visits 2 and 3, subjects will be expected to wear the study lenses for at least 16 hours. The total duration of subject participation will be up to 22 days.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
170
Inclusion Criteria

Not provided

Exclusion Criteria
  • Habitual PRECISION1, Clariti 1-Day, and DAILIES TOTAL1 contact lens wearers.
  • Any monovision and multifocal lens wearers.
  • Other protocol-specified exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PRECISION1, then Clariti 1-DaySomofilcon A contact lensesVerofilcon A contact lenses worn first, with somofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) for 8 days in a daily disposable modality.
PRECISION1, then Clariti 1-DayVerofilcon A contact lensesVerofilcon A contact lenses worn first, with somofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) for 8 days in a daily disposable modality.
Clariti 1-Day, then PRECISION1Verofilcon A contact lensesSomofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) for 8 days in a daily disposable modality.
Clariti 1-Day, then PRECISION1Somofilcon A contact lensesSomofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) for 8 days in a daily disposable modality.
Primary Outcome Measures
NameTimeMethod
Least Squares Mean Distance VA (logMAR) With Study LensesDay 8, each study lens type

Distance visual acuity (VA) was assessed with study lenses in place. VA was collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal visual acuity), with a negative value denoting better than 20/20 visual acuity.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (8)

Alcon Investigator 6645

🇺🇸

Shawnee Mission, Kansas, United States

Alcon Investigator 6418

🇺🇸

Tallahassee, Florida, United States

Alcon Investigator 6402

🇺🇸

Medina, Minnesota, United States

Alcon Investigator 8028

🇺🇸

Wichita Falls, Texas, United States

Alcon Investigator 6614

🇺🇸

Franklin Park, Illinois, United States

Alcon Investigator 8106

🇺🇸

San Francisco, California, United States

Alcon Investigator 6565

🇺🇸

Maitland, Florida, United States

Alcon Investigator 8046

🇺🇸

Granville, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath